- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,771
- Gender
- Male
- Political Leaning
- Progressive
Chinese trials for Gilead’s antiviral drug to treat coronavirus still far from reaching patient recruitment goals | South China Morning Post
Antiviral remdesivir is being trialled as a treatment for the novel coronavirus in 10 hospitals in Wuhan
Researchers have recruited more than 230 patients for the trials so far, short of the 760 targeted
Clinical trials of an experimental antiviral drug said to “show promise” in treating the deadly coronavirus are still far from fulfilling patient recruitment targets more than two weeks in, raising questions about whether they can be completed within previously projected timelines.
Double-blind trials of Gilead Sciences’ drug, remdesivir, are now taking place in 10 hospitals in Wuhan, vice-minister of science and technology Xu Nanping said at a press conference on Friday.
=========================================
Don't they have enough infected people in China?
Antiviral remdesivir is being trialled as a treatment for the novel coronavirus in 10 hospitals in Wuhan
Researchers have recruited more than 230 patients for the trials so far, short of the 760 targeted
Clinical trials of an experimental antiviral drug said to “show promise” in treating the deadly coronavirus are still far from fulfilling patient recruitment targets more than two weeks in, raising questions about whether they can be completed within previously projected timelines.
Double-blind trials of Gilead Sciences’ drug, remdesivir, are now taking place in 10 hospitals in Wuhan, vice-minister of science and technology Xu Nanping said at a press conference on Friday.
=========================================
Don't they have enough infected people in China?